Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ou T"'
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 465-477 (2022)
Xiaosong Chen,1,* Ping Wang,2,* Tongwen Ou,1 Jin Li1 1Department of Urology, Xuanwu Hospital of The Capital Medical University, Xuanwu Hospital, Beijing, People’s Republic of China; 2Department of General Practice, Beijing Xicheng District
Externí odkaz:
https://doaj.org/article/db5073250b94463fb86040746172c88b
Publikováno v:
OncoTargets and Therapy, Vol Volume 13, Pp 11277-11288 (2020)
Huifeng Bi,1,2 Zhenhua Shang,1 Chunsong Jia,1 Jiangtao Wu,1 Bo Cui,1 Qi Wang,1 Tongwen Ou1 1Department of Urology, Xuanwu Hospital Capital Medical University, Beijing, People’s Republic of China; 2Department of Urology, Jincheng General Hospital, J
Externí odkaz:
https://doaj.org/article/bde7c002ae9342fc94b6757dc052acfe
Publikováno v:
Cancer Management and Research, Vol Volume 12, Pp 9471-9483 (2020)
Huifeng Bi,1,2 Zhenhua Shang,1 Chunsong Jia,1 Jiangtao Wu,1 Bo Cui,1 Qi Wang,1 Tongwen Ou1 1Department of Urology, Xuanwu Hospital Capital Medical University, Beijing, People’s Republic of China; 2Department of Urology, Jincheng General Hospital, J
Externí odkaz:
https://doaj.org/article/7a6d109adce7423f90e078f6b3c4d6d7
Publikováno v:
OncoTargets and Therapy, Vol Volume 15, Pp 681-682 (2022)
Bi H, Shang Z, Jia C, et al. Onco Targets Ther. 2020;13:11277–11288. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised following the authors request to replace duplicated images in Figur
Externí odkaz:
https://doaj.org/article/cfc357c4c00b4e28b8810929ddd418d9
Publikováno v:
Cancer Management and Research, Vol Volume 10, Pp 1177-1190 (2018)
Zhenhua Shang, Jukun Wang, Xu Wang, Hao Yan, Bo Cui, Chunsong Jia, Qi Wang, Xin Cui, Jin Li, Tongwen Ou Department of Urology, Xuanwu Hospital Capital Medical University, Beijing, People’s Republic of China Introduction: The aim of this study was t
Externí odkaz:
https://doaj.org/article/adb9e66ce291464a99c2eedbcb519b67
Publikováno v:
Zhongliu Fangzhi Yanjiu, Vol 49, Iss 9, Pp 982-986 (2022)
Borderline resectable pancreatic ductal adenocarcinoma accounts for approximately 20% of newly diagnosed pancreatic cancer patients. This type of adenocarcinoma is between resectable and unresectable. It has a high degree of heterogeneity and feature
Externí odkaz:
https://doaj.org/article/a7305c5e16b8436db08340c3e68028ca